Skip to content

Biocytogen Pharmaceuticals (Beijing) Co Ltd Sustainability Reports

The company operates as a global biotechnology enterprise focusing on antibody-based drug discovery, gene-editing services, and preclinical pharmacology evaluations. It provides off-the-shelf humanized animal models and fully human antibody sequences for worldwide biomedical collaborations.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

LEI: 549300F4L1TRSHBRCU87

FIGI: BBG00KK8MLD0

5 reports from 2022 to 2025